Fig. 3.

ICG-001 inhibits in vivo gastric tumor growth. a and b Tumors were produced by MGC-803. MGC-803 Cell (2× 10⁶) were injected subcutaneously in the right flank of nude mice per mouse respectively (n = 4). And when the tumors developed in 7 days, the mice were randomly distributed into two groups, and were untreated or treated with ICG-001 (50 mg/kg/day); c Tumor growth curves were monitored during the experimental period (n = 40). Data represent the mean ± SEM of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control